Main > ONCOLOGY (**) > Lymphoma>NHL>B-Cell>PMBCL R/R* > TREAT > Co: USA. M. PembrolizuMAb

---

Co: USA. M. PembrolizuMAb's subsections
(*) USA Approval Date: ?
Company
Patent>Assignee; Claims; No.; Etc.
Patent>Total USA No.: 5
Patent>UpDate: 2019. 12.31.
TradeMark
TradeMark Web-Site

Co: USA. M. PembrolizuMAb's products
This section has no products